| Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder HM Abdolmaleky, S Yaqubi, P Papageorgis, AW Lambert, S Ozturk, ... Schizophrenia research 129 (2-3), 183-190, 2011 | 234 | 2011 |
| Emerging drugs for the treatment of anxiety JW Murrough, S Yaqubi, S Sayed, DS Charney Expert opinion on emerging drugs 20 (3), 393-406, 2015 | 233 | 2015 |
| COMT-inhibitors may be a promising tool in treatment of marijuana addiction R Shafa, HM Abdolmaleky, S Yaqubi, C Smith, SN Ghaemi American Journal on Addictions 18 (4), 322-322, 2009 | 15 | 2009 |
| Entacopne (comtan)(R) as novel anti-craving treatment in substance abuse and dependence R Shafa, HM Abdolmaleky, S Yaqubi, C Smith, N Ghaemi AMERICAN JOURNAL ON ADDICTIONS 17 (4), 332-333, 2008 | 1 | 2008 |
| Utilizing (Catechol-O-Methyltransferase) COMT-Inhibition Effect in Detoxification off Buprenorphine, Methadone and Other Opioids R Shafa, HM Abdolmaleky, M Eskandari, S Yaqubi, SN Ghaemi AMERICAN JOURNAL ON ADDICTIONS 22 (3), 309-310, 2013 | | 2013 |
| Inhibition of COMT (Catechol-O-Methyl-Transferase), Activity as an Innovative Approach in Pharmacotherapy of Alcohol Dependence R Shafa, HM Abdolmaleky, MR Eskandari, S Yaqubi, N Ghaemi AMERICAN JOURNAL ON ADDICTIONS 21 (4), 395-395, 2012 | | 2012 |
| Modulation of Dopamine Pathways Via COMT-Inhibitors May Provide an Alternative Strategy in Smoke Cessation (Pilot) R Shafa, HM Abdolmaleky, MR Eskandari, S Yaqubi, N Ghaemi AMERICAN JOURNAL ON ADDICTIONS 20 (4), 376-377, 2011 | | 2011 |
| COMT Inhibition May Offer a New Hope in Treatment of Cocaine Craving (Pilot) R Shafa, HM Abdolmaleky, S Yaqubi, SN Ghaemi AMERICAN JOURNAL ON ADDICTIONS 19 (4), 379-379, 2010 | | 2010 |
| Entacapone (COMTAN)® in treatment of bipolar depression in patients with or without co-morbidity of substance abuse R Shafa, HM Abdolmaleky, S Yaqubi, C Smith, R Koziol, N Ghaemi The International Journal of Neuropsychopharmacology 11, 181, 2008 | | 2008 |
